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Objective: Identify factors related to the health system that lead to a late diagnosis 
of breast cancer in Brazil.
Method: We performed a systematic review in the PubMed and LILACS databases 
using as keywords “Breast cancer,” “system of health” and “Brazil or Brasil.” We 
evaluated the content of the articles using the PRISMA methodology based on 
PICTOS. The final date was 12/16/2015. We were able to identify 94 publications 
in PubMed and 43 publications in LILACS. After assessing the title and summary, 
and excluding 21 repeated publications, we selected 51 publications for full 
evaluation. At this stage, we excluded 21 articles, with 30 publications remaining 
for study. 
Results: The population coverage is low, and there are problems related to the 
quality of mammography. Patients with lower income, nonwhite and less educated 
are more vulnerable. We observed punctual and initial experiences in breast 
cancer screening. Diagnosis and treatment flows must be improved. The inequality 
in mortality reflects the differences related to screening structure and treatment. 
Better results are observed in well-structured services. 
Conclusion: There are several barriers in the health system leading to advanced 
stage at diagnosis and limiting the survival outcomes. The establishment of a 
rapid and effective order for diagnosis and treatment, based on hierarchical flow, 
are important steps to be improved in the public health context.
Keywords: breast neoplasms/prevention and control, health systems, screening 
programs, mammography, Unified Health System.
introduction
Breast cancer is a worldwide problem, with 1.7 million 
new cases a year. Half of the cases are in developed countries, 
but 62% of deaths occur in developing nations. Mortality 
in the United States is declining, a fact attributed to early 
diagnosis by mammography and to improvements in 
treatment. In South America, however, incidence and 
mortality are increasing.1 Breast cancer is diagnosed in 
advanced stages in countries with limited resources due 
to a deficit in the ability to promote early detection, diag-
nosis and treatment. To assess the complexity of the health 
system in relation to breast cancer, the Breast Health 
Global Initiative (BHGI)2 sought to categorize the orga-
nization levels of different countries in relation to breast 
cancer, so that the basic level encourages breast self-exam, 
the limited level refers to the availability of diagnostic 
ultrasound and mammography, the increased level includes 
diagnostic mammography with opportunistic breast 
screening, and the maximum level refers to organized 
population mammary screening.2 In the United States, the 
rate of mammography screening is high, but in countries 
with budget limits there are no effective screening programs, 
and in some cases access to treatment is limited.1
Survival in developed countries is around 73%, and 
57% in developing countries. In developing countries, the 
incidence of breast cancer is lower, while the incidence/
mortality ratio is higher than in developing countries.1 
Due to the economic and logistical limitations in Brazil, 
mammographic screening is not a widespread reality, a 
fact that is reflected in the high number of patients diag-
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nosed at an advanced stage, due to the absence of an 
organized network aimed at the early diagnosis of breast 
cancer. There is no organized mammographic screening, 
only isolated experiments.3-5
When assessing the barriers related to mammography 
screening, they can be synthetically divided into those 
related to the health system, those related to education 
or knowledge, and those related to adherence or attitude.6 
In Brazil, there are innumerous factors related to adher-
ence/attitude, including age, socioeconomic condition 
and formal education. The education/knowledge catego-
ry includes the factors described above, associated with 
the fact that mammography is not often indicated by 
physicians, and patients do not seek tests when they do 
not present symptoms or if they fear pain or cancer.5 Bar-
riers related to the health system are difficult to assess as 
there is no specific indicator. Thus, a critical evaluation 
of the barriers related to the health system, which impact 
on the screening of breast cancer, is justified. 
Method
We conducted a literature review using a systematic 
search methodology to evaluate the barriers related to 
mammography screening in Brazil. We did not evaluate 
the methodology or quality of the study, but publica-
tions that expressed this matter. We searched the PubMed 
database using as keywords “Breast Cancer” and “system 
of health” and “Brazil or Brasil”. In the LILACS database, 
we used as keywords “Breast neoplasms” and “Health 
Systems.” PRISMA7 methodology (Figure 1) based on 
PICTOS (Population- Intervention- Comparator- Out-
come- Timing- Setting; Table 1) was adopted for article 
selection. The articles were grouped according to the 
subject addressed, trying to identify possible factors that 
express the limitation of the health system.
On 12/16/2015, using this methodology, we were able 
to identify 94 articles in the PubMed database and 43 pub-
lications in the Lilacs. We evaluated title and summary and, 
after excluding 21 repetitive publications, we selected 51 
FIGURE 1 PRISMA records flow diagram.
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publications for full evaluation. At this stage, we excluded 
21 articles, seven related to mortality, five presenting post-
-treatment Brazilian Unified Health System (SUS, in the 
Portuguese acronym) data, three presenting global aspects 
related to different types of cancer, and six for different 
reasons (breast changes, social support to cancer, costs in 
the private system, ethics, cervical cancer and stage of di-
agnosis). Aiming at a better understanding of the barriers 
related to the health system in Brazil, 30 publications re-
mained in the study, and these were the basis of our bib-
liographic review. The data are summarized in Figure 1. 
The data are mostly qualitative. We chose to present grouped 
results according to the subject presented (Table 2).
CAAE Study No. 56123516.1.0000.5505, approved 
by the Research Ethics Committee of Unifesp under 
No. 0650/2016 on June 1, 2016.
results
With 30 articles selected according to PICTOS,4-6,8-34 we 
attempted to create groups according to contexts, namely: 
TABLE 1 Summary of the findings observed according to PICOTS. 
Proposal Inclusion
P/ Population Breast cancer in Brazil Breast cancer in Brazil; dependence to the SUS
I/ Intervention Mammography 
Health management
Mammography; screening
Health management
C/ Comparison Factors related to the Health System Mammography machine: population-based coverage, availability, quality; management; 
type of screening
O/ Outcome Results found Experience in screening, vulnerable populations, diagnostic flow, clinical stage at diagnosis, 
treatment and mortality
T/ Time Any Any
S/ Study type Any Any
TABLE 2 Main results summarized.
PICO Summary of findings
Goal Mammography 50-69 years, bi-annually
P/ Population SUS system population dependent on governmental actions
Subgroup without MMG: absence of health plan, non-white, low income
Patients over the age of 40 who never underwent MMG
Distance from place of residence to treatment greater than 150 km
I/ Intervention SUS Screening type
Mammography control done by the SISMAMA
MMG usually diagnostic
Opportunistic screening through collective action to meet demand
Organized screening does not exist
Organized screening being implemented at a single center in the country
C/ Comparison Comparison
Inadequate mammography coverage
Inadequate biannual recall
Unsatisfactory quality of mammography in the SUS
O/ Outcome Result
Difficulty in patient flow, from diagnosis to treatment
Diagnosis in symptomatic phase
Advanced clinical stage of cancer at diagnosis negatively influencing survival
Mortality: Private < well-structured public < regular public services 
Gradual improvement in the supply of MMG and outcomes related to cancer staging, with no defined indicators
Increased incidence and increased mortality: Midwest, North and Northeast regions
Increased incidence and decrease in mortality: South and Southeast
MMG: mammography.
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problem overview (3), management-related articles (4), 
mammogram and population coverage (3), assessment 
of factors related to non-adherence to mammography (4), 
the experience of oportunistic (4) and organized screening 
(2), difficulties in establishing a diagnostic flow (2), and 
mortality (8). Table 1 summarizes the findings. 
Three articles were selected based on an overall assess-
ment of the problem.8-10 The Ministry of Health held a 
workshop where mammographic screening was discussed. 
Observing positive experiences, but considering the Euro-
pean position and recommendations of the BHGI, the 
Ministry restricted the orientation of mammographic 
screening to the age group of 50-69 years, a guideline that 
should be followed by health managers.9 A 2012 thesis 
discussed mammography screening and public health 
conditions in Brazil, and is a good roadmap for health 
managers.10 Evaluating the problem in a global way, there 
is a difference in terms of the distribution of mammogra-
phy machines, with a higher proportion of unused devices 
in the North/Northeast of Brazil. 30-35% of women un-
dergo proper mammography, mainly in the private sector, 
and 80% do not have referral from a doctor. The mean time 
between presentation of symptoms and diagnosis is 72-185 
days, which leads to high rates of advanced stage diagnosis, 
with 37.0% in stage III and IV, different from that observed 
in the private sector, where this rate is 16.2%.8 
Regarding health management11,12 and information 
systems for the support of health management,13,14 four 
articles were selected. Assessing the origin-destination flow 
of outpatient visits and hospitalizations related to breast 
cancer, we observed that the treatment is generally per-
formed in large cities and in reference centers, and patients 
travel distances greater than 150 km from their city source.11 
Despite the existance of different information systems on 
breast cancer, they are little explored.12 The SISMAMA 
system showed promising results with 50% of the examina-
tions performed in the age group 50-69 years and about 
66% of mammography reports were performed in a period 
inferior to 30 days.13 National coverage is low, including 
32% of women in the 50-59 age group and 25% in the 60-69 
age group, though this actually depends on the age group 
of the macro-region. In general, the coverage of women in 
the 50-59 age group is higher in the Southern and South-
eastern states, and lower in the North and Northeast.14 
Evaluating the mammograms, we must observe the 
population-based coverage, the differences in quality of 
the exam, the differences related to form of the diagnosis 
(symptomatic or asymptomatic), and factors related to 
the failure to undergo mammography. Despite regional 
differences in population coverage in Brazil,14 a study 
carried out in the state of Goiás15 evaluated coverage based 
on the number of mammography machines, the number 
of devices in operation for the SUS, where the state cover-
age was 61%, divided into 13% coverage by the SUS and 
48% by non-SUS.15 Also in the state of Goiás, the study 
assessed the quality of the machines16 using performance 
tests. The authors found initial conformity of 64.1%, and 
77.1% of unacceptable rates (< 70%), which is a percentage 
considered high, since low quality mammography predis-
poses to incorrect diagnoses.16 
There are studies that attempt to evaluate the factors 
related to non-mammography.17-20 Considering biannual 
mammograms, the authors evaluated a population sample 
of women over the age of 40 (n=290) from the state of São 
Paulo and found that non-white elderly women (> 70 years) 
with low income (≤ 5 minimum salaries) were more likely 
to fail to undergo mammography. However, in this study, 
the SUS was responsible only for 28.8% of the population 
undergoing mammography.17 A study carried out in the 
capital of the state of Piauí (n=433), evaluating women 
aged 40-69 years, revealed that 24.7% of the sample had 
never undergone mammography, and among those who 
had undergone the examination, 17.5% had mammograms 
more than two years earlier, and 66.6% in the previous year. 
In this population, 56.3% of the exams were funded by the 
SUS system. Factors related to failure to undergo mam-
mography included non-white ethnicity, low educational 
index, low income and absence of health plan, highlighting 
the importance of the social and racial context for not 
undergoing mammography.18 This fact is more serious 
when the regular repetition of the exams is assessed. A study 
conducted in the city of Taubaté (state of São Paulo) showed 
that correct adherence to biannual repetition occurred in 
only 30% of the population, and differential access to pub-
lic or private health services contributed to such a reduced 
rate.19 Another factor that must be carefully evaluated is 
the result of mammography, both diagnostic and screening. 
The detection rate was 8.8 cases/1,000 mammograms in 
asymptomatic patients (screening) and 61.7/1,000 mam-
mograms in symptomatic patients, reflecting a large num-
ber of advanced stage at diagnosis in symptomatic women.20
There is no organized screening in Brazil, but collective 
mobilization/actions to provide mammography and or-
ganized screening models are described.4,21-23 A collective 
action to provide mammography performed in the city of 
Marília (state of São Paulo) yielded 0.84 diagnosed cas-
es/1,000 mammograms. The cost of the mobilization per 
case diagnosed was considered high, suggesting the supe-
riority of implementing screening services.22 Investigating 
a population of 4,037 women in the city of Porto Alegre 
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(state of Rio Grande do Sul), with patients being divided 
into symptomatic or asymptomatic, the authors found 
nine cases in 7,656 women-years,4 with 60% adherence in 
one year, suggesting that opportunistic screening in sites 
with a high incidence of breast cancer is positive. Regard-
ing lost years of life, an increased risk of death from breast 
cancer was observed in the range of 50-59 years, and a 
significant increase in the range 40-49 years.23
Regarding organized screening, we must consider 
the regional experience in the interior of the state of São 
Paulo3,5,24 with a biannual screening proposal in the age 
range of 40-69 years. In the first two years of the project, 
17,964 women were investigated and 76 cases were diag-
nosed, with an increase in the early stage rate from 14.5% 
to 43.2%. Similar to other studies, the authors describe 
that 42.1% of this sample had never undergone a previous 
mammogram in their lives, especially among women of 
low socioeconomic class and low education. The strat-
egy of mobile units and the family health program were 
important in identifying these women.5 After years of 
initiating the project, the authors noted that the rate of 
early stage in asymptomatic women was 70.8%, with 
only 5.6% reporting difficulty in obtaining a mammog-
raphy examination, and the success of the program was 
due to intense community involvement associated with 
free mammography, tests performed according to the 
norms of the health system, and mammography per-
formed near the patients’ home.24 The authors report 
the importance of the nurse in the management and 
operationalization of the screening action.6 
As for the issue of health system,25,26 difficulty in es-
tablishing a diagnosis and treatment flow is observed, which 
contributes to increase the time between diagnosis and 
beginning of treatment. Thus, in Brazil, 36.9% of the pa-
tients take more than 60 days between the diagnosis and 
the start of treatment. The women most susceptible to 
delay are not white, do not have a partner, have little formal 
education, are at an early stage of the disease and covered 
only by the SUS system.25 It is true that there are multiple 
steps since the initial evaluation, with false-negative results, 
follow-up, diagnosis and treatment, which requires a struc-
tured and agile system to optimize time. Failure to give 
access for asymptomatic women, fear, low education, age 
and false-negative results contribute to the delay.26 
In terms of the relationship between mortality and 
the health system,27-30 a study carried out in the city of 
Juiz de Fora, state of Minas Gerais (n=282), revealed, in 
the univariate analysis, that patients treated in public 
hospitals presented worse survival. However, in this pop-
ulation, the advanced stage of the disease at the time of 
diagnosis was more frequent in public hospitals, possibly 
explaining the absence of this relationship in the multi-
variate model.27 Another study carried out in Juiz de Fora 
(n=437) showed in the multivariate model that public 
services and non-white race/color had higher mortality 
risk due to breast cancer.28 In the state of Rio de Janeiro, 
there was an inverse association between the presence of 
mammography and mortality.29 Another study conduct-
ed in Rio de Janeiro evaluating 15 hospital units (n=310) 
showed better survival30 in patients treated in services 
with private health plans and Oncology Centers (p=0.02), 
hospitals with a large number of procedures (p=0.007), 
and the time between diagnosis and treatment lower than 
6 months (p<0.0001), which emphasizes the importance 
of well-structured public services. 
For the analysis of trend and mortality curves,31-34 in 
the period between 1980 and 2002, there was increase 
mortality by breast cancer in the southern region of the 
country.31 In the period from 1991 to 2010, there was an 
increase in mortality rates in Brazil, in the North, North-
east and Midwest regions, although they remained stable 
in the South region and decreased in the Southeast region. 
This is similar to that observed in developed countries 
and reinforces the need for appropriate screening and 
treatment programs.32 This disparity was also observed 
in the Brazilian macro-regions in the period from 1980 
to 2009, probably due to regional inequalities. There was 
decline and stabilization in regions with a higher socio-
economic level and the opposite in regions with low so-
cioeconomic status.33 A study comparing mortality in the 
USA and in the Brazilian Oncology Hospital showed that, 
for the same staging, overall survival was similar. How-
ever, when comparing clinical stages, there was a higher 
percentage of patients in advanced clinical stage in Brazil, 
which negatively affected the survival of the group. The 
conclusion was that, by undergoing the appropriate treat-
ment, the main factor associated with high mortality is 
the advanced cancer stage at diagnosis.34
discussion
Screening for breast cancer through mammography is the 
best methodology for secondary prevention in the gen-
eral population, promoting early detection in the asymp-
tomatic phase, leading to a substantial reductions in 
morbidity and mortality caused by late diagnosis. A 
meta-analysis with articles from the Cochrane database 
on mammographic screening did not show a reduction in 
mortality risk when evaluating studies with adequate ran-
domization. However, the evaluation of studies with sub-
optimal randomization yielded a reduction in mortality 
Breast cancer screening in Brazil. Barriers related to the health system
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risk of approximately 25%, and about 19% after all these 
studies were grouped.35 The reduction in breast cancer 
mortality in several developed countries was probably due 
to the association of screening programs and improve-
ments in adjuvant therapy.1 We draw attention to an 
American study that compared historical data from the 
Surveillance, Epidemiology, and End Results (SEER), as-
sessing clinical stage, and found a reduction in advanced 
stages of cancer close to 8%.36 However, this study was 
much questioned for evaluating global data, with part of 
the population not being screened and population cover-
age below the satisfactory value.37 
Changes in mortality occur mainly after the age of 
50 years, with the age limit being 69 to 74 years. Therefore, 
to achieve a reduction in breast cancer mortality, mam-
mography should be performed on a large scale at the 
general population level. The Brazilian Society of Mastol-
ogy suggests that the initial age should be 40 years,38 
which was the guideline established by the American 
Cancer Society until 2015, updated in 2016 to 45 years.39 
Eusoma,40 the US Task Force and the Brazilian Ministry 
of Health,10 suggest that this exam should be performed 
from the age of 50 years.5 
In developing countries, the majority of the popula-
tion has low incomes, being dependent on government 
actions and public health infrastructure, with multiple 
diseases competing for limited resources. Public health 
practices are linked to national guidelines, available meth-
odologies and capacity to absorb demand in the public 
network. In this context, the BHGI argues that organized 
population-based mammography screening should be 
conducted only in developed countries.2
There is now a lot of literature against and in favor of 
mammographic screening. Pro-mammography factors 
include: decreasing the size of diagnostic lesions, with 
implications for diagnosis and treatment; studies demon-
strating a decrease in mortality due to breast cancer; years 
of life saved; an acceptable rate of hyperdiagnosis (1 to 
10%); the frequency of subtypes; and the progression of 
carcinoma in situ. It is worth mentioning that, in order to 
achieve this goal, it is necessary to have population cover-
age, good quality exams, associated with a fast and efficient 
diagnostic flowchart.35,37,40 Cons include partial evaluation 
of systematic reviews;35 discussions about the actual de-
cline of advanced tumors in the US;36 hyperdiagnosis 
(31%);36 and studies that show that there are lives saved by 
mammography screening, but their numbers are limited.41 
Usually, those who deal with the patient are in favor of 
screening,37,39 while epidemiologists are more cautious,41 
presenting a somewhat more negative view.36 Thus, many 
studies suggest that the patient should know all the points 
involved in mammographic screening, and should be aware 
of the pros and cons associated with the potential gain 
related to screening,41 which is possible from a theoretical 
point of view, but very difficult in medical practice. 
The truth is that organizing a mammographic screen-
ing requires technology, money, training, education, 
proper staffing and patient adherence. Every program 
must have a beginning, a middle and an end,38 that is, 
measures from planning to the appropriate destination 
of suspected and positive cases, and community inter-
vention.5,24 Associated with this, the team should be 
trained to evaluate mammographic screening, and not 
only mammographic diagnoses, respecting quality and 
logistics standards, as is the case in Europe.40 Barriers 
related to the health system are the main limiting factors 
for not performing mammography in developing coun-
tries. This fact is influenced by accessibility to the ser-
vices of health, unsatisfactory medical adhesions, cost 
of the exams and difficulties related to complementary 
exams and follow-up. The evaluation of factors related 
to the health system and adherence to mammography 
is complex, since there is no specific indicator. We noted 
in our review, problems related to information manage-
ment, distribution of mammography machines in the 
public network, quality of mammography, and other 
issues associated with the operationalization of organized 
screening and effective treatment. 
In developing countries, these issues are more evident, 
as health resources are limited. And while there are con-
troversies in the literature, the negative points of breast 
screening are considered, as health resources are used 
preferentially in more effective programs such as cervical 
cancer. In these countries, BHGI suggests self-examination 
in conjunction with diagnostic mammography and ul-
trasonography.2 The IARC encourages self-examination 
education and clinical breast examination as a screening 
methodology in low-income countries, with sufficient 
evidence for mammographic screening in the 50-69 age 
group in developed countries.42 In Brazil, there is eco-
nomic and structural diversity. The Brazilian census 
(PNAD survey) revealed that mammography examinations 
are less frequent in the North region, compared to the 
higher examination rate in the Southeast,43 which proves 
the uneven mammographic coverage in the country.14 
Another reflex of the association of screening and treat-
ment are the trend curves related to mortality, with a rise 
in the North, Northeast and Midwest, stabilization in the 
South, and a decrease in the Southeast region.32 It should 
be noted that the decrease in mortality is only observed 
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in places where the association between screening and 
treatment is effective.1 Similarly, as examples of Southern4 
and Southeastern5 Brazil, there are programs in the struc-
turing phase that have presented promising results. 
In Sweden, the benefits of mammography screening 
are well known.35 In Europe, the rules for mammograph-
ic screening are clear and the indicators are acceptable 
and desirable,40 but understanding the multiple steps 
involved in the process is only achieved once the program 
is properly structured.38 Evaluating screening quality 
control, for example, we observed the quality of mam-
mography, the recall rates for complementary exams, 
diagnostic rates in incidence and prevalence screening, 
rates of invasive tumors, proportion of tumors measur-
ing less than 1.0-1.5 cm, sensitivity of the needle biopsy, 
benign/malignant open biopsy ratios, and time between 
examinations and surgery.38 In Brazil, since organized 
screening is not done, there is much to be implemented 
in terms of quality. In the experience in the interior of 
the state of São Paulo, symptomatic patients are observed 
in the initial phase of network structuring,5 which is not 
ideal in screening programs. However, structuring the 
service, acquiring technology, training staff38 and par-
ticipating in quality programs, coupled with adherence 
strategies,24 represent important steps to achieve improve-
ment. Access to mammography refers to: presence of this 
technology and ease of access by the general population, 
including the quality of the exams and the possibility of 
performing complementary tests for biopsy and differ-
ential diagnosis.38 Other regional centers need to be set 
up, as proposed in Europe.40 Lack of knowledge of pro-
cesses makes management-related analyses difficult, and 
these are often partially evaluated, based on mammog-
raphy, test results, and cancer mortality. Organized 
screening targets asymptomatic patients and should be 
associated with a hierarchical and effective network of 
examinations until diagnosis, which should be rapid, 
comprehensive, and effective. This overrides the alloca-
tion of technological, financial and human resources. 
It is estimated that the SUS system is responsible for 
75% of health at the national level, with the supplemen-
tary healthcare system being responsible for the rest of 
the population. Breast cancer is a population-based disease 
and, therefore, the limitations of the SUS affect disease 
diagnosis, leading to advanced stages and respective in-
creased mortality curves.32 Logistical and technological 
limitation leads to delayed examinations and diagnosis,8 
with low population coverage,32,43 seen in our study popu-
lation, and is one of the main barriers related to the health 
system, as presented in the results section. The SISMAMA 
system is an important auxiliary tool for health manage-
ment,13 but there is much to be done. There is a need for 
evaluation of populations vulnerable to mammogra-
phy,3,5,17,18 as well as strategies to improve their access.5,24 
Law No. 11.664 authorized on 04/29/2008 access to 
mammography for women over 40, but it was superseded 
by Directive No. 1253 on 12/11/2013, which limited mam-
mography to the age group of 50-69 years, according to 
the public policies related to the age range that should 
undergo mammography. Currently, the Ministry of Health 
suggests that the examination should target the age range 
of 50-69 years,5 in keeping with the installed technologi-
cal base and availability to the population. A Brazilian 
publication questions the possibility of screening in the 
age group of 45-69 years,44 as recommended in 2016 by 
the American Cancer Society.39 The difficulties and results 
observed in Brazilian literature3,5,24,38 limit the proper 
analysis of the subject, due to the lack of results related 
to the second round screening, where we evaluate breast 
cancer detection rate in subsequent-screening examina-
tions and indicators related to the control of quality.40
The health system must be structured, allowing access 
to mammography, complementary examinations, diag-
nosis and effective treatment. There is a migration of 
patients within the SUS that reflects its hierarchical sys-
tem, but logistical and structural limitations increase the 
time between diagnosis and treatment.25 Mammograph-
ic screening is the responsibility of primary health care, 
and is associated with procedures of small and medium 
complexity. Oncological treatment is the responsibility 
of Oncology Centers (CACONs), which perform proce-
dures of medium and high complexity. Directive No. 3535 
issue on 09/02/1988, and Health Ministry Directive No. 
741 issue on 12/19/2005 regulate the hierarchy of the 
oncology system, but because they are treatment services, 
the stage at the beginning of treatment is a reflection of 
the diagnostic conditions and the structuring of the health 
system. Hospital cancer registries show us advanced 
stages of diagnosis, which reveals the logistic limitations 
prior to treatment, associated with longer periods until 
diagnosis,8 with many symptomatic patients presenting 
advanced disease.8 It is interesting that breast cancer pa-
tients in high-demand centers and referral hospitals have 
better survival rates,30 possibly due to logistical facilities 
and use of treatment protocols. 
The absence of prospective and randomized studies 
on the subject in the literature evaluated is a limitation 
of our study, but this has already been reported in other 
developing countries.45 We report the main results found 
in Brazil comparing them with the main results reported 
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in the literature. We attempted to present the subject in 
a global manner, not judging its merit, in order to evalu-
ate the results of the absence of organized screening, pre-
senting possible reasons that could influence the facts 
and be used to further structure the health system. Our 
study does not aim to judge the health system, but to 
contribute to the reflection on the subject, since a struc-
ture is being constructed and progress has occurred, as 
shown in the trend curves of different macro-regions. 
In view of the scenario presented above, we observed 
that breast cancer patients in Brazil are mostly dependent 
on the public health system, the SUS, which is responsible 
for the diagnosis and treatment of the vast majority of the 
population. Limitations of the health system are clear 
given the advanced stage of disease at diagnosis, and limit 
survival outcomes. Measures related to increased quantity, 
quality and regularity of mammography will allow adequate 
coverage of asymptomatic patients. Establishing a rapid 
and effective diagnostic flow, coupled with appropriate 
treatment, within a hierarchical context are important steps 
to be taken to promote women’s health. 
conclusion
In Brazil, the number of mammography machines in 
operation is limited, time to diagnosis is high, and disease 
stage at diagnosis is advanced. Population coverage is low, 
with problems related to the quality of mammography. 
Lower income, less educated and non-white patients are 
the most vulnerable. There are reports of collective actions 
to provide mammographic examination, and early expe-
riences of opportunistic screening. The flow of diagnosis 
and treatment should be improved. Inequality in mortal-
ity is a reflection of screening and treatment limitations, 
so that well-structured public services perform better. 
resuMo
Rastreamento do câncer de mama no Brasil. Barreiras 
relacionadas ao sistema de saúde
Objetivo: Identificar fatores relacionados ao sistema de 
saúde que determinam atraso no diagnóstico do câncer 
de mama no Brasil. 
Método: Utilizou-se metodologia de revisão sistemática 
nas bases de dados PubMed e LILACS, pesquisando os 
termos “Breast cancer”, “system of health” e “Brazil or 
Brasil”. Não se avaliou a qualidade da publicação, mas seu 
conteúdo, sendo ele categorizado em função da metodo-
logia PRISMA baseada no PICTOS. Na data limite de 
16/12/2015, foi possível identificar 94 publicações na Pu-
bMed e 43 publicações na LILACS. Avaliando o título e 
resumo, e excluindo-se 21 publicações repetidas, foi pos-
sível identificar 51 publicações para avaliação completa, na 
qual foram excluídos 21 artigos, restando 30 publicações. 
Resultados: Observou-se que a base de mamógrafos é li-
mitada, o tempo até o diagnóstico é elevado, e o estadio ao 
diagnóstico é avançado. A cobertura populacional é baixa, 
havendo problemas na qualidade da mamografia. As pa-
cientes de menor renda, menor escolaridade e etnia não 
branca são as mais vulneráveis. Observam-se exemplos de 
mutirões e experiências iniciais de rastreamento. Necessita-
-se de aprimoramento do fluxo de diagnóstico e tratamen-
to. A desigualdade na mortalidade é reflexo da estrutura 
para rastreamento e tratamento, observando-se melhores 
resultados em serviços públicos bem estruturados. 
Conclusão: Há diversas barreiras relacionadas ao sistema 
de saúde que refletem no estádio avançado ao diagnóstico 
e limitam os resultados na sobrevida. O estabelecimento 
de um fluxo de diagnóstico e tratamento rápidos e efeti-
vos, dentro de um contexto hierarquizado, são importan-
tes etapas a serem aprimoradas dentro do contexto da 
saúde pública. 
Palavras-chave: neoplasias da mama/prevenção e con-
trole, sistemas de saúde, programas de rastreamento, ma-
mografia, Sistema Único de Saúde (SUS).
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